Comparison |
| Alternate Manufacturer Number |
| 3567708 | 2008134 | 2069276 | 3760550 |
| Container Type |
Single-Dose Kit | Bottle | Bottle | Bottle | Bottle |
| Country of Origin |
Unknown | Unknown | United States | Unknown | Ireland |
| Dosage Form |
Injection | Tablet | Tablet | Tablet | Tablet |
| Generic Drug Code |
| | 31095 | 35079 | 44426 |
| Generic Drug Name |
Cabotegravir | Dolutegravir Sodium | Raltegravir Potassium | Dolutegravir Sodium | Bictegravir Sodium / Emtricitabine / Tenofovir Alafenamide Fumarate |
| NDC Number |
49702026423 | 49702022613 | 00006047761 | 49702022813 | 61958250101 |
| Quantity |
| 30 Tablets | 60 Tablets | 30 Tablets | 30 Tablets |
| Storage Requirements |
Requires Refrigeration | | | | |
| Strength |
600 mg / mL | 10 mg | 100 mg | 50 mg | 50 mg - 200 mg - 25 mg |
| Type |
Intramuscular | | Unit of Use, Chewable | | |
| UNSPSC Code |
51343700 | 51343204 | 51343201 | 51343204 | 51343800 |
| Volume |
3 mL | | | | |
| Application |
HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Features and Benefits |
- Cabotegravir extended-release injectable suspension
- For gluteal intramuscular use only
- Indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection
- Contents: 1 Single-dose vial, 1 Vial Adapter, 1 Syringe, 1 Injection needle (23 gauge, 1-1/2 Inch)
|
|
|
- TIVICAY is a prescription medicine that is used together with other antiretroviral medicines to treat Human Immunodeficiency Virus (HIV‑1) infection in adults and children who weigh at least 66 pounds
- Film Coated
|
|
